Treatment After Progression of Fulvestrant Among Metastatic Breast Cancer Patients
Condition(s):Breast CancerLast Updated:February 15, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:February 15, 2019Completed
Condition(s):Metastatic Breast CancerLast Updated:March 30, 2021Terminated
Condition(s):Breast CancerLast Updated:June 18, 2019Completed
Condition(s):Breast CancerLast Updated:August 1, 2012Completed
Condition(s):Metastatic Breast CancerLast Updated:January 19, 2023Completed
Condition(s):Estrogen Receptor Positive; Invasive Breast Carcinoma; Recurrent Breast Carcinoma; Stage IV Breast Cancer AJCC v6 and v7Last Updated:July 23, 2018Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:December 9, 2019Completed
Condition(s):Estrogen Receptor-positive Breast Cancer; HER2/Neu Negative; Stage IV Breast Cancer AJCC v6 and v7Last Updated:October 15, 2021Active, not recruiting
Condition(s):Metastatic Breast CancerLast Updated:August 24, 2021Terminated
Condition(s):Metastatic Breast CancerLast Updated:October 16, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.